Patient info Open main menu

L01EX12 larotrectinib

ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)

This site has the patient leaflet or the SPC of 3 medicines in this group.

Active substance: Larotrectinib – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
        1. L01EX Other protein kinase inhibitors 94 medicines
          1. L01EX12 larotrectinib 3 medicines

Medicines

MedicineLegal category
Vitrakvi 100 mg hard capsules SPC Prescription only (POM)
Vitrakvi 20 mg / ml oral solution SPC –
Vitrakvi 25 mg hard capsules SPC Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01EX12

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.